An apparatus for the treatment or prevention of osteopenia and osteoporosis, stimulating bone growth, preserving or improving bone mineral density, and inhibiting adipogenesis is described where one embodiment may comprise a motor configured to be in vibrational conductance with an area of the subject,...
The clinical use for melatonin in bone-grafting procedures, in reversing bone loss due to osteopenia and osteoporosis, and in managing periodontal disease is discussed. 展开 关键词: melatonin menopause osteoblasts osteoclasts osteopenia osteoporosis Per2 ...
If you have osteopenia, your bones are also losing mass, and they could break more easily. If you continue to lose more bone density, osteopenia becomes osteoporosis. When you go for a bone density test, your density is compared to someone of your sex and race who has peak bone mass,...
There are a variety of pharmaceutical agents that have been recommended for the treatment of osteopenia and osteoporosis including hormone replacement therapy, selective estrogen receptor modulator therapy, anti-resorptive therapy. In addition patients with osteoporosis who have failed anti-resorptive therapy...
There is high-level evidence for the anti-fracture efficacy of treatment in women with osteoporosis, particularly if there is prevalent fracture; the evidence is less compelling for women with osteopenia, with or without a fracture, and for men. The rigorously investigated drugs reported to reduce...
Prevention and treatment of nonpostmenopausal osteoporosis PURPOSE: The causes, prevention, and treatment of osteoporosis in specific populations are discussed. SUMMARY: Osteoporosis and osteopenia affect 44 millio... LB Hansen,SF Vondracek 被引量: 0发表: 0年 IV. Meta-Analysis of Raloxifene for the...
After the approval ofFosamaxin 1995 by the FDA, Merck & Co launched a marketing campaign to promote the preventive aspects of this drug for osteoporosis and osteopenia. Part of that campaign saw a more than 10-fold increase in bone measuring devices, sponsored by the same drug manufacturers, ...
The objective of the current study was to evaluate the psychometric properties of the OPSAT-Q and, therefore, substantiate its use for patient satisfaction evaluation in studies of bisphosphonate treatment for osteoporosis and osteopenia. Methods OPSAT-Q development The OPSAT-Q was recently developed...
Osteoporosis is a systemic disease characterized by osteopenia and degeneration of bone microstructure.Its main complications are all kinds of brittle bone fracture,which is also the main reason for disability and death.Osteoporosis has become a serious public health and social problem.The therapy of ...
you haveosteopenia, your bones are weaker than they used to be, but they're not weak enough for you to be diagnosed withosteoporosis. That’s a condition in which your bones are so thin they break easily. If your bones keep getting thinner over time, osteopenia can turn into osteoporosis...